[ORIENT] YoY TTM Result on 30-Sep-2016 [#3]

Stock
[ORIENT] ORIENTAL HOLDINGS BHD
Announcement Date
17-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -3.0%
YoY- -32.93%
Quarter Report
Latest QR
Upcoming QR
ORIENT's Result
ORIENT's Financial Summary
View:
Show?
TTM Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 5,483,416 6,714,560 6,466,195 4,911,649 4,108,908 3,248,003 2,747,598 12.20%
PBT 480,424 606,535 667,030 207,429 405,140 423,047 283,997 9.15%
Tax -119,031 -127,370 -116,650 -61,954 -75,651 -82,263 -65,286 10.52%
NP 361,393 479,165 550,380 145,475 329,489 340,784 218,711 8.72%
-
NP to SH 376,215 503,785 438,970 206,524 307,944 266,616 153,994 16.04%
-
Tax Rate 24.78% 21.00% 17.49% 29.87% 18.67% 19.45% 22.99% -
Total Cost 5,122,023 6,235,395 5,915,815 4,766,174 3,779,419 2,907,219 2,528,887 12.47%
-
Net Worth 6,621,620 6,554,931 6,084,572 5,648,274 25,452,825 4,891,580 4,702,080 5.86%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 285,366 248,144 124,056 124,054 124,068 43,434 24,821 50.20%
Div Payout % 75.85% 49.26% 28.26% 60.07% 40.29% 16.29% 16.12% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 6,621,620 6,554,931 6,084,572 5,648,274 25,452,825 4,891,580 4,702,080 5.86%
NOSH 620,393 620,393 620,362 620,553 620,393 620,514 620,081 0.00%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 6.59% 7.14% 8.51% 2.96% 8.02% 10.49% 7.96% -
ROE 5.68% 7.69% 7.21% 3.66% 1.21% 5.45% 3.28% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 883.91 1,082.36 1,042.33 791.50 146.03 523.44 443.10 12.19%
EPS 60.64 81.21 70.76 33.28 10.94 42.97 24.83 16.03%
DPS 46.00 40.00 20.00 20.00 4.41 7.00 4.00 50.21%
NAPS 10.6738 10.5663 9.8081 9.102 9.0458 7.8831 7.583 5.86%
Adjusted Per Share Value based on latest NOSH - 620,553
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 883.86 1,082.31 1,042.27 791.70 662.31 523.54 442.88 12.20%
EPS 60.64 81.20 70.76 33.29 49.64 42.98 24.82 16.04%
DPS 46.00 40.00 20.00 20.00 20.00 7.00 4.00 50.21%
NAPS 10.6733 10.5658 9.8076 9.1043 41.0269 7.8846 7.5792 5.86%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 6.50 6.20 6.58 6.96 6.98 7.60 8.84 -
P/RPS 0.74 0.57 0.63 0.88 4.78 1.45 2.00 -15.26%
P/EPS 10.72 7.63 9.30 20.91 63.78 17.69 35.60 -18.12%
EY 9.33 13.10 10.75 4.78 1.57 5.65 2.81 22.13%
DY 7.08 6.45 3.04 2.87 0.63 0.92 0.45 58.26%
P/NAPS 0.61 0.59 0.67 0.76 0.77 0.96 1.17 -10.28%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 27/11/19 27/11/18 22/11/17 17/11/16 19/11/15 20/11/14 29/11/13 -
Price 6.50 5.92 6.55 6.80 7.04 7.15 8.61 -
P/RPS 0.74 0.55 0.63 0.86 4.82 1.37 1.94 -14.83%
P/EPS 10.72 7.29 9.26 20.43 64.33 16.64 34.67 -17.76%
EY 9.33 13.72 10.80 4.89 1.55 6.01 2.88 21.63%
DY 7.08 6.76 3.05 2.94 0.63 0.98 0.46 57.68%
P/NAPS 0.61 0.56 0.67 0.75 0.78 0.91 1.14 -9.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment